339 related articles for article (PubMed ID: 19341734)
21. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1).
Al Chawaf A; Xu K; Tan L; Vaccarino FJ; Lovejoy DA; Rotzinger S
Peptides; 2007 Jul; 28(7):1406-15. PubMed ID: 17644218
[TBL] [Abstract][Full Text] [Related]
22. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss.
Le Mevel JC; Olson KR; Conklin D; Waugh D; Smith DD; Vaudry H; Conlon JM
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1335-43. PubMed ID: 8945972
[TBL] [Abstract][Full Text] [Related]
24. Structural evolution of urotensin-I: reflections of life before corticotropin releasing factor.
Lovejoy DA
Gen Comp Endocrinol; 2009 Oct; 164(1):15-9. PubMed ID: 19393654
[TBL] [Abstract][Full Text] [Related]
25. Corticotropin releasing factor influences aggression and monoamines: modulation of attacks and retreats.
Carpenter RE; Korzan WJ; Bockholt C; Watt MJ; Forster GL; Renner KJ; Summers CH
Neuroscience; 2009 Jan; 158(2):412-25. PubMed ID: 18992791
[TBL] [Abstract][Full Text] [Related]
26. Central administration of corticotropin-releasing hormone stimulates locomotor activity in juvenile chinook salmon (Oncorhynchus tshawytscha).
Clements S; Schreck CB; Larsen DA; Dickhoff WW
Gen Comp Endocrinol; 2002 Feb; 125(3):319-27. PubMed ID: 11884077
[TBL] [Abstract][Full Text] [Related]
27. Extrapituitary effects of corticotropin-releasing factor.
Lenz HJ
Horm Metab Res Suppl; 1987; 16():17-23. PubMed ID: 3327796
[TBL] [Abstract][Full Text] [Related]
28. Mammalian pharmacology of the fish neuropeptide urotensin I.
MacCannell KL; Lederis K
Fed Proc; 1983 Jan; 42(1):91-5. PubMed ID: 6848383
[TBL] [Abstract][Full Text] [Related]
29. Central and peripheral cardiovascular effects of angiotensin III in trout.
Mimassi N; Lancien F; Le Mével JC
Ann N Y Acad Sci; 2009 Apr; 1163():469-71. PubMed ID: 19456389
[TBL] [Abstract][Full Text] [Related]
30. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
Erb S; Kayyali H; Romero K
Pharmacol Biochem Behav; 2006 Sep; 85(1):206-13. PubMed ID: 16987545
[TBL] [Abstract][Full Text] [Related]
31. CRF-related peptides contribute to stress response and regulation of appetite in hypoxic rainbow trout.
Bernier NJ; Craig PM
Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R982-90. PubMed ID: 15932968
[TBL] [Abstract][Full Text] [Related]
32. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
Diamant M; Kashtanov SI; Fodor M; de Wied D
Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
[TBL] [Abstract][Full Text] [Related]
33. CRF and stress in fish.
Flik G; Klaren PH; Van den Burg EH; Metz JR; Huising MO
Gen Comp Endocrinol; 2006 Mar; 146(1):36-44. PubMed ID: 16403502
[TBL] [Abstract][Full Text] [Related]
34. Effects of intracerebroventricular administered fluoxetine on cardio-ventilatory functions in rainbow trout (Oncorhynchus mykiss).
Kermorgant M; Lancien F; Mimassi N; Tyler CR; Le Mével JC
Gen Comp Endocrinol; 2014 Sep; 205():176-84. PubMed ID: 24681193
[TBL] [Abstract][Full Text] [Related]
35. Altered responsivity to central administrations of corticotropin-releasing factor in rats with a history of opiate exposures.
Blatchford KE; Choi EA; McNally GP
Behav Neurosci; 2006 Oct; 120(5):1169-74. PubMed ID: 17014268
[TBL] [Abstract][Full Text] [Related]
36. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
[TBL] [Abstract][Full Text] [Related]
37. Urocortin and cardiovascular protection.
Huang Y; Yao XQ; Lau CW; Chan YC; Tsang SY; Chan FL
Acta Pharmacol Sin; 2004 Mar; 25(3):257-65. PubMed ID: 15000874
[TBL] [Abstract][Full Text] [Related]
38. Effects of the traditional Japanese medicine Unkei-to on the corticotropin-releasing factor-induced increase in locomotor activity.
Terawaki K; Koike K; Yuzurihara M; Kase Y; Takeda S; Aburada M; Murakami K; Ohno S; Suzuki N; Inoue M
Pharmacol Biochem Behav; 2004 Aug; 78(4):799-803. PubMed ID: 15301938
[TBL] [Abstract][Full Text] [Related]
39. Comparison of brain arginine-vasotocin and corticotrophin-releasing factor for physiological responses in chicks.
Tachibana T; Saito ES; Saito S; Tomonaga S; Denbow DM; Furuse M
Neurosci Lett; 2004 Apr; 360(3):165-9. PubMed ID: 15082159
[TBL] [Abstract][Full Text] [Related]
40. Heads or tails? Stressor-specific expression of corticotropin-releasing factor and urotensin I in the preoptic area and caudal neurosecretory system of rainbow trout.
Bernier NJ; Alderman SL; Bristow EN
J Endocrinol; 2008 Mar; 196(3):637-48. PubMed ID: 18310459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
